BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 34859333)

  • 1. The relationship of blood CDC42 level with Th1 cells, Th17 cells, inflammation markers, disease risk/activity, and treatment efficacy of rheumatoid arthritis.
    Li Y; Yang W; Wang F
    Ir J Med Sci; 2022 Oct; 191(5):2155-2161. PubMed ID: 34859333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.
    Ye Z; Chen L; Fang Y; Zhao L
    J Clin Lab Anal; 2022 Jan; 36(1):e24112. PubMed ID: 34788483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell division control protein 42 correlates with lower disease risk and its elevation predicts better treatment response, and inhibits T-helper 17 cell differentiation in rheumatoid arthritis.
    Yang Y; Huang L; Wu B
    Inflammopharmacology; 2022 Dec; 30(6):2117-2125. PubMed ID: 35737168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating Th17 and Th1 cells expressing CD161 are associated with disease activity in rheumatoid arthritis.
    Miao J; Zhang K; Lv M; Li Q; Zheng Z; Han Q; Guo N; Fan C; Zhu P
    Scand J Rheumatol; 2014; 43(3):194-201. PubMed ID: 24392804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum CDC42 is increased during tumor necrosis factor inhibitor treatment, and its elevation correlates with satisfactory treatment response in rheumatoid arthritis patients.
    Yang Y; Wu B; Tian P; Huang L
    Int J Rheum Dis; 2023 Aug; 26(8):1521-1528. PubMed ID: 37382403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MALT1 regulates Th2 and Th17 differentiation
    Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
    Front Immunol; 2022; 13():913830. PubMed ID: 35967391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of T helper 17 cells are associated with disease activity in patients with rheumatoid arthritis.
    Kim J; Kang S; Kim J; Kwon G; Koo S
    Ann Lab Med; 2013 Jan; 33(1):52-9. PubMed ID: 23301223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between Serum Chemokine Ligand 20 Levels and Disease Activity and Th1/Th2/Th17-Related Cytokine Levels in Rheumatoid Arthritis.
    Wang L; Hong X; Du H
    J Interferon Cytokine Res; 2023 Nov; 43(11):512-517. PubMed ID: 37815793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with the most advanced rheumatoid arthritis remain with Th1 systemic defects after TNF inhibitors treatment despite clinical improvement.
    Kosmaczewska A; Swierkot J; Ciszak L; Szteblich A; Chrobak A; Karabon L; Partyka A; Szechinski J; Wiland P; Frydecka I
    Rheumatol Int; 2014 Feb; 34(2):243-53. PubMed ID: 24221190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal variation of serum PCSK9 in ulcerative colitis: association with disease activity, T helper 1/2/17 cells, and clinical response of tumor necrosis factor inhibitor.
    Deng J; Jiang Y; Luan L; Fu S; Huang M; Dai Z; Liao Y; Guo S; Fu Y
    Ir J Med Sci; 2024 Feb; 193(1):165-172. PubMed ID: 37420045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating PCSK9 relates to aggravated disease activity, Th17/Treg imbalance, and predicts treatment outcome of conventional synthetic DMARDs in rheumatoid arthritis patients.
    Meng Y; Zheng X; Zhang Z; Geng H; Li X
    Ir J Med Sci; 2023 Dec; 192(6):3187-3194. PubMed ID: 36826711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inter-alpha-trypsin inhibitor heavy chain 4: A serologic marker relating to disease risk, activity, and treatment outcomes of rheumatoid arthritis.
    He K; He S; Su M
    J Clin Lab Anal; 2022 Mar; 36(3):e24231. PubMed ID: 35064701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation of circulating cell division cycle 42 expression with Th1, Th2, and Th17 cells, adhesion molecules, and biochemical indexes in coronary heart disease patients.
    Zhou M; Wu J; Tan G
    Ir J Med Sci; 2022 Oct; 191(5):2085-2090. PubMed ID: 34811660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer's disease.
    Zhang Y; Niu C
    Ann Clin Transl Neurol; 2022 Sep; 9(9):1428-1436. PubMed ID: 35976992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Th1-Th17 Ratio as a New Insight in Rheumatoid Arthritis Disease.
    Bazzazi H; Aghaei M; Memarian A; Asgarian-Omran H; Behnampour N; Yazdani Y
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):68-77. PubMed ID: 29512371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between albumin to fibrinogen ratio, C-reactive protein to albumin ratio and Th17 cells in patients with rheumatoid arthritis.
    He Y; Tang J; Wu B; Yang B; Ou Q; Lin J
    Clin Chim Acta; 2020 Jan; 500():149-154. PubMed ID: 31672633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long non-coding RNA NEAT1 and its targets (microRNA-21 and microRNA-125a) in rheumatoid arthritis: Altered expression and potential to monitor disease activity and treatment outcome.
    Yang J; Wang S; Liu L; Wang J; Shao Y
    J Clin Lab Anal; 2021 Dec; 35(12):e24076. PubMed ID: 34708894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined treatment of etanercept and MTX reverses Th1/Th2, Th17/Treg imbalance in patients with rheumatoid arthritis.
    Lina C; Conghua W; Nan L; Ping Z
    J Clin Immunol; 2011 Aug; 31(4):596-605. PubMed ID: 21562776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of Th17 CD4+ T cells in early rheumatoid arthritis: a marker of anti-CCP seropositivity.
    Arroyo-Villa I; Bautista-Caro MB; Balsa A; Aguado-Acín P; Nuño L; Bonilla-Hernán MG; Puig-Kröger A; Martín-Mola E; Miranda-Carús ME
    PLoS One; 2012; 7(8):e42189. PubMed ID: 22870298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell division control 42 elevates during infliximab therapy, and its increment relates to treatment response in ulcerative colitis patients.
    Liu L; Liu Q; Chang J; Dong X; Ma W
    J Clin Lab Anal; 2022 Jun; 36(6):e24477. PubMed ID: 35527674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.